Programme SOM0044 for Parkinson’s Disease
SOM0044 is a small molecule for the treatment of Parkinson’s disease.
Roche’s gantenerumab fails in Phase II/III inherited Alzheimer’s trial
Roche’s gantenerumab is being developed to treat patients with Alzheimer’s. Credit: F. Hoffmann-La Roche Ltd.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
SOM Biotech
SOM Biotech is an Artificial Intelligence AI drug discovery and...
About
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the development of therapies for orphan indications through the proprietary AI-based drug discovery technology.
FollowMake an Enquiry
-
Pilloxa
Pilloxa creates digital and remote solutions to optimise clinical trials...
About
Pilloxa creates digital and remote solutions to optimise clinical trials and patient support programmes through supporting medical adherence and patient retention.
FollowMake an Enquiry
-
ACTide by Nubilaria
Nubilaria Srl is an Information Technology (IT) company founded in...
About
Nubilaria Srl is an Information Technology (IT) company founded in 1999. Our company has its origins in the design, management and distribution of complex database systems and innovative IT services under strict international security policies.
FollowMake an Enquiry